Laboratory for Cell and Molecular Biology, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, 330 Brookline Ave., W/BL 548, 02215, Boston, Massachusetts, USA.
Environ Health Prev Med. 2003 Jan;7(6):239-45. doi: 10.1007/BF02908882.
Erythropoietin is the prime regulator of red blood cell production. However, recent evidence suggests that the hormone has multiple effects outside the hematopoietic system. Functional receptors have been identified on a wide variety of normal and malignant cell types, and numerous biologic effects of the hormone on these cells have been observed both in vitro and in vivo. These findings are causing a reassessment of the understanding of erythropoietin physiology. Moreover, there are important implications for the use of recombinant erythropoietin in the clinical setting.
促红细胞生成素是红细胞生成的主要调节因子。然而,最近的证据表明,该激素在造血系统之外具有多种作用。已经在各种正常和恶性细胞类型上鉴定出功能性受体,并且已经在体外和体内观察到该激素对这些细胞的许多生物学作用。这些发现正在促使人们重新评估对促红细胞生成素生理学的理解。此外,重组促红细胞生成素在临床环境中的应用也具有重要意义。